Medtech company Johnson & Johnson and ACCESS, a physician-led management services organization, have signed a multiyear preferred portfolio agreement to expand adoption of advanced cardiac electrophysiology technologies in ASCs.
Through the agreement, ACCESS-affiliated ASCs will be able to use a portfolio that includes 3D mapping, intracardiac imaging, radiofrequency ablation and pulsed-field ablation technologies, according to an Aug. 10 news release from ACCESS.
The partnership will help ASCs expand access to cardiac arrhythmia treatments and support the delivery of cardiac electrophysiology care in the outpatient setting.
“The movement of appropriately selected electrophysiology procedures into ambulatory surgery centers represents one of the most important developments in cardiovascular care today,” Vijay Swarup, MD, executive director of Arizona Heart Rhythm Center in Phoenix, said in the release. “This agreement gives ACCESS-affiliated centers a more efficient pathway to evaluate, acquire and implement advanced technologies while developing the clinical and operational infrastructure required to build sustainable, high-quality outpatient electrophysiology programs.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
